0000886163-21-000136.txt : 20211117 0000886163-21-000136.hdr.sgml : 20211117 20211117170646 ACCESSION NUMBER: 0000886163-21-000136 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211116 FILED AS OF DATE: 20211117 DATE AS OF CHANGE: 20211117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAMATTINA JOHN L CENTRAL INDEX KEY: 0001216074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 211421422 MAIL ADDRESS: STREET 1: 81 WYMAN ST STREET 2: POST OFFICE BOX 9046 CITY: WALTHAM STATE: MA ZIP: 02454 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-11-16 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001216074 LAMATTINA JOHN L 5980 HORTON STREET, SUITE 405 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2021-11-16 4 M 0 4835 32.3 A 30233 D Common Stock 2021-11-16 4 S 0 4835 161.8571 D 25398 D Non-Qualified Stock Option (right to buy) 32.3 2021-11-16 2021-11-16 4 M 0 4835 0.0 D 2023-06-11 Common Stock 4835 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.36 to $164.12, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and fully vested on the first anniversary of the grant date. By: Charles S. Berkman For: John L. LaMattina 2021-11-17